Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 116 publications
Clinical Impact of Heart Failure Readmissions in HeartMate 3 Left Ventricular Assist Device Recipients.
Journal: ASAIO journal (American Society for Artificial Internal Organs : 1992)
Published: August 17, 2026
Effect of Vutrisiran According to Baseline Tafamidis Use in Transthyretin Amyloidosis With Cardiomyopathy: Insights From HELIOS-B.
Journal: Journal of the American College of Cardiology
Published: June 22, 2026
Recent updates in the management of atrial fibrillation in patients with cardiac amyloidosis.
Journal: Future cardiology
Published: May 18, 2026
Guideline-Directed Medical Therapy Use and Dose Optimization After Transcatheter Aortic Valve Replacement in Patients With Persistent Heart Failure With Reduced Ejection Fraction.
Journal: Journal of cardiac failure
Published: May 08, 2026
Inpatient Initiation of Target-Dose ACE Inhibitors and Lower Risk of Death or Kidney Failure in Veterans With HFrEF: Results From the National DCVA-HF Registry.
Journal: Journal of cardiac failure
Published: March 31, 2026
Supporting the forgotten ventricle: Hybrid strategies for right heart failure in durable LVAD patients.
Journal: The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation
Published: March 11, 2026
Clinical and imaging profiling of restrictive cardiomyopathies: insights into amyloid, sarcoid, and iron overload phenotypes.
Journal: Heart failure reviews
Published: February 12, 2026
Acoramidis in transthyretin amyloid cardiomyopathy: expanding evidence from ATTRibute-CM.
Journal: Future cardiology
Published: February 09, 2026
Effect of vutrisiran on components of health status in transthyretin amyloidosis with cardiomyopathy: the HELIOS-B study.
Journal: European journal of heart failure
Published: January 21, 2026
Baroreflex activation therapy in heart failure - the Barostim-Enabled Neurohormonal Intervention for Improving Treatment of Heart Failure (BENEFIT-HF) trial rationale and design.
Journal: Journal of cardiac failure
Published: January 16, 2026
Vutrisiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy and Renal Impairment: Analyses From HELIOS-B.
Journal: Journal of cardiac failure
Published: October 24, 2025
Last Updated: 09/26/2026